Estrogen production and metabolism in endometriosis

Annals of the New York Academy of Sciences

DOI 10.1111/j.1749-6632.2002.tb02767.x PMID 11949967

Abstract

Aromatase activity is absent in normal endometrium. In contrast, aromatase is expressed aberrantly in endometriosis, which gives rise to strikingly high levels of aromatase activity in this tissue. Both aromatase expression and activity are stimulated by PGE2. This results in local production of estrogen, which induces PGE2 formation and establishes a positive feedback cycle. Another abnormality in endometriosis, that is, deficient 17beta-HSD type 2 expression, impairs the inactivation of estradiol to estrone. These molecular aberrations collectively favor accumulation of increasing quantities of estradiol and PGE2 in endometriosis. The clinical relevance of these findings was exemplified by the successful treatment of an unusually aggressive case of postmenopausal endometriosis using an aromatase inhibitor.

Topics

aromatase expression endometriosis estrogen production, Bulun endometriosis estrogen metabolism aromatase, prostaglandin E2 estradiol positive feedback endometriosis, 17beta-HSD type 2 deficiency endometriosis estradiol, aromatase inhibitor endometriosis treatment postmenopausal, local estrogen production endometriotic tissue molecular, aberrant aromatase activity endometriosis versus normal endometrium, endometriosis estrogen biosynthesis PGE2 positive feedback, estradiol inactivation impairment endometriosis pathogenesis, aromatase inhibitor aggressive postmenopausal endometriosis case
PMID 11949967 11949967 DOI 10.1111/j.1749-6632.2002.tb02767.x 10.1111/j.1749-6632.2002.tb02767.x

Cite this article

Bulun, S. E., Yang, S., Fang, Z., Gurates, B., Tamura, M., & Sebastian, S. (2002). Estrogen production and metabolism in endometriosis. *Annals of the New York Academy of Sciences*. https://doi.org/10.1111/j.1749-6632.2002.tb02767.x

Related articles